23andMe | Investor Day Presentation Deck

Slide schematic 2/2

list 1/1 title 1/1

Components 2

bullet headline

Tools 1

list/bullet: Introduction -- Anne Wojcicki, CEO and Co-Founder 23andMe Therapeutics Therapeutics program overview -- Kenneth Hillan, Head of Therapeutics Target discovery vision -- Joe Arron, Chief Scientific Officer, Th

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

list-presentation 100%

The slide uses a hierarchical list to organize the presentation flow.

Find anything

23andMe | Investor Day Presentation Deck | 78 slides · slide 3